(Q37961836)

26 August 2017

1 reference

title

Prolactin and human breast cancer: a review (English)

1 reference

26 August 2017

H. Nagasawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A221222

15 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=221222

15 January 2023

publication date

1 March 1979

1 reference

full work available at URL

26 August 2017

https://api.elsevier.com/content/article/PII:0014296479900379?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

https://api.elsevier.com/content/article/PII:0014296479900379?httpAccept=text/plain

15 January 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

European Journal of Cancer

15 January 2023

published in

1 reference

26 August 2017

15

1 reference

26 August 2017

3

1 reference

26 August 2017

267-279

1 reference

Prolactin and murine mammary tumorigenesis: a review

26 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin concentrations in benign breast disease throughout the menstrual cycle

15 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin concentrations in patients with breast cancer.

15 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Letter: Plasma-prolactin in breast cancer

15 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

l-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: A preliminary report

15 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma prolactin in breast cancer

15 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer

15 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Disordered nocturnal prolactin regulation in women with breast cancer

15 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Circulating hormone concentrations in women with breast cancer

15 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Etiology of Human Breast Cancer: A Review2

15 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function

15 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Studies on human sexual development. IV. Fetal pituitary and serum, and amniotic fluid concentrations of prolactin

15 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Dynamic Evaluation of Prolactin Secretion during the Early Hours of Life in Human Newborns

15 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin and oestradiol levels at different stages of puberty

15 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The Adrenarche: Prolactin, Gonadotropins, Adrenal Androgens, and Cortisol

15 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin levels during puberty

15 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Radioimmunoassay of human prolactin (PRL)

15 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Influence of age on serum prolactin levels in women and men

15 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The relationship of plasma prolactin to 17-B oestradiol in women with tumours of the breast

15 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

A Homologous Radioimmunoassay for Human Prolactin1

15 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations

15 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Circadian Periodicity of Serum Prolactin Concentration in Man

15 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Human Prolactin: 24-Hour Pattern with Increased Release during Sleep

15 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Relation of sleep-entrained human prolactin release to REM-nonREM cycles

15 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma prolactin and its relationship to risk factors in human breast cancer

15 January 2023

31

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer

15 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Sleep-related endocrine rhythms

15 January 2023

34

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation

15 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma testosterone and prolactin in the menstrual cycle

15 January 2023

39

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin concentrations in ovulatory but infertile women: treatment with bromocriptine

15 January 2023

40

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

A radioimmunoassay for human prolactin

15 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Twenty-four hour prolactin (PRL) secretory patterns during pregnancy

15 January 2023

43

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female. I. A study during physiological lactation

15 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Effect of breast-feeding on pituitary-ovarian function after childbirth

15 January 2023

45

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment.

15 January 2023

47

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Augmentation of prolactin secretion by estrogen in hypogonadal women

15 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The Influence of Exogenous Estrogen on the Circadian Periodicity of Circulating Prolactin in Women

15 January 2023

50

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma prolactin and breast cancer.

15 January 2023

51

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Menopausal Estrogens and Breast Cancer

15 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The roles of estrogen and progesterone in breast and genital cancer

15 January 2023

53

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The pill, estrogens, and the breast.Epidemiologic aspects

15 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Effects of Long-Term Administration of Estrogen on the Occurrence of Mammary Cancer in Women

15 January 2023

55

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

15 January 2023

57

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

An epidemiologic study of breast cancer

15 January 2023

58

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Exogenous Estrogens and Breast Cancer in Women With Natural Menopause 2

15 January 2023

59

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Effects of oral contraceptive steroids on pituitary prolactin secretion

15 January 2023

60

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The role of hormones in the etiology of human breast cancer

15 January 2023

61

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Oral contraceptives and breast neoplasia

15 January 2023

62

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Oral Contraceptives and Reduced Risk of Benign Breast Diseases

15 January 2023

63

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Cancer risk as related to use of oral contraceptives during fertile years

15 January 2023

64

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients

15 January 2023

65

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women

15 January 2023

66

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Reserpine use in relation to breast cancer

15 January 2023

68

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Matched-pairs study of reserpine use and breast cancer

15 January 2023

70

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Rauwolfia derivatives and breast cancer

15 January 2023

71

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Reserpine and Breast Cancer in a Retirement Community

15 January 2023

72

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota

15 January 2023

73

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland

15 January 2023

74

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin levels in women using copper IUDs

15 January 2023

75

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin and growth hormone release in response to sequential stimulation by arginine and synthetic TRF

15 January 2023

76

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women

15 January 2023

77

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Measurement of pituitary hormones: clinical applications. 5. Prolactin

15 January 2023

78

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin response to thyrotropin releasing hormone in normal subjects

15 January 2023

79

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer

15 January 2023

80

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, T.S.H. and M.S.H

15 January 2023

81

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Incidence of cancer in men on a diet high in polyunsaturated fat.

15 January 2023

82

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices

15 January 2023

83

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Diet and cancer of endocrine target organs

15 January 2023

84

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Diet and endocrine-related cancer

15 January 2023

85

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer

15 January 2023

86

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population

15 January 2023

87

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma prolactin, thyroid-stimulating hormone, follicle-stimulating hormone and luteinizing hormone in normal British and Japanese women

15 January 2023

88

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin, oestrogen, and lipids in breast fluid

15 January 2023

90

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Oestrogen in breast fluid

15 January 2023

91

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease

15 January 2023

92

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma hormone profiles in populations at different risk for breast cancer

15 January 2023

94

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma hormone levels in different ethnic populations of women

15 January 2023

95

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women

15 January 2023

96

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

An assessment of the effects of hormones on short term organ cultures of human breast carcinomata

15 January 2023

99

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

15 January 2023

Prolactin receptor

100

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Hormone binding by human mammary carcinoma

15 January 2023

102

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

DNA synthesis of human, mouse, and rat mammary carcinomas in vitro: influence of insulin and prolactin

15 January 2023

105

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

In Vitro Model Systems for the Study of Hormone-Dependent Human Breast Cancer

15 January 2023

107

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Prolactin in breast cancer

15 January 2023

109

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Brain catecholamines and breast cancer: a hypothesis

15 January 2023

111

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female. II. A study during inhibition of lactation by bromergocryptine

15 January 2023

112

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Effect of prolactin suppression on gonadotrophic secretion in the puerperium

15 January 2023

113

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility

15 January 2023

114

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Hormonal Changes Induced by Bromocriptine (CB-154) at the Early Stage of Treatment

15 January 2023

115

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Endocrine profile of ergot alkaloids

15 January 2023

116

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands

15 January 2023

117

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Suppressive effect of L-dopa on human prolactin release during sleep

15 January 2023

118

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Precise selection of breast cancer patients with bone metastasis for endocrine ablation

15 January 2023

119

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The response of breast cancer patients with bone pain to L-dopa

15 January 2023

122

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Hypophysectomy in Metastatic Breast Cancer

15 January 2023

123

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

Elevated Serum Prolactin Levels after Pituitary-Stalk Section in Man

15 January 2023

124

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

The Role of Prolactin in Carcinogenesis

15 January 2023

125

1 reference

https://api.crossref.org/works/10.1016/0014-2964(79)90037-9

15 January 2023

Identifiers

1 reference

26 August 2017

1 reference